FDA inspection
Rhode Island Blood Center, A Division of New York Blood Center, Inc.: FDA inspection ending Nov 7, 2016
FDA inspection 995774 · Voluntary Action Indicated (VAI) · Providence, RI
Key facts
| Inspection ID | 995774 |
|---|---|
| Firm | Rhode Island Blood Center, A Division of New York Blood Center, Inc. |
| FEI number | 1270007 |
| Address | 405 Promenade St |
| City | Providence |
| State | RI |
| ZIP | 02908 |
| Country | United States |
| Fiscal year | 2017 |
| Inspection end date | Nov 7, 2016 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data